Corcept Therapeutics Inc Reports Significant Revenue Growth and Net Income Increase in Q4 and ...
Continued Commercial Success and Advancements in Clinical Programs Mark a Strong Year for the Biopharmaceutical Company
Stay updated with breaking news from Bill Guyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Continued Commercial Success and Advancements in Clinical Programs Mark a Strong Year for the Biopharmaceutical Company
MENLO PARK, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the...
Operator: Good day. And welcome to the Corcept Therapeutics Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
MENLO PARK, Calif., March 28, 2023 -- Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic,... | March 28, 2023
Operator: Greetings, and welcome to the Corcept Therapeutics Conference Call. At this time, all participants are in a listen-only mode.